Chad Conner

Chief Operating Officer at HOMETOWN INTERNATIONAL, INC.

49 year

Health Technology

Retail Trade

Profile

Chad S.
Conner is currently the Chief Executive Officer & Director at Mycrodose Therapeutics, Inc. since 2020 and the Chief Operating Officer at Makamer Holdings, Inc. since 2022.
Previously, he served as the Chief Executive Officer & Director at Pure Ratios Holdings, Inc. from 2015 to 2021.

Chad Conner active positions

Companies	Position	Start
HOMETOWN INTERNATIONAL, INC.	Chief Operating Officer	2022-03-31
Mycrodose Therapeutics, Inc. Mycrodose Therapeutics, Inc. BiotechnologyHealth Technology Mycrodose Therapeutics, Inc. is a US-based pharmaceutical company that specializes in developing advanced drug delivery systems using DEA Schedule I & III drugs and other compounds to treat cancer-related conditions, mental health, and cognitive degenerative diseases. Mycrodose Therapeutics is one of the few private companies that have been granted a Schedule I license and approved by the United States Drug Enforcement Agency (DEA), State of Attorney Generals Research Advisory Board, and the US Food & Drug Administration (FDA) to research four psychedelic compounds: psilocybin, LSD, MDMA, and DMT. The company is based in San Diego, CA, and was founded in 2020. The company's IP-protected sustained microdosing technology™ is a safer and smarter approach to delivering pharmaceutical compounds to patients of all ages, allowing for an expandable and scalable business model. Chad S. Conner has been the CEO of the company since 2020.	Chief Executive Officer	2020-10-31

All active positions of Chad Conner

Former positions of Chad Conner

Companies	Position	End
Pure Ratios Holdings, Inc. Pure Ratios Holdings, Inc. Pharmaceuticals: OtherHealth Technology Pure Ratios Holdings, Inc. develops and manufactures traditional Chinese medicines with cannabis including the integration of hemp derived CBD. The company was founded by William A. Conner in 2015 and is headquartered in San Diego, CA.	Chief Executive Officer	2021-02-28

See the detail of Chad Conner's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Chad Conner's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
HOMETOWN INTERNATIONAL, INC.	Retail Trade

Private companies	2
Pure Ratios Holdings, Inc. Pure Ratios Holdings, Inc. Pharmaceuticals: OtherHealth Technology Pure Ratios Holdings, Inc. develops and manufactures traditional Chinese medicines with cannabis including the integration of hemp derived CBD. The company was founded by William A. Conner in 2015 and is headquartered in San Diego, CA.	Health Technology
Mycrodose Therapeutics, Inc. Mycrodose Therapeutics, Inc. BiotechnologyHealth Technology Mycrodose Therapeutics, Inc. is a US-based pharmaceutical company that specializes in developing advanced drug delivery systems using DEA Schedule I & III drugs and other compounds to treat cancer-related conditions, mental health, and cognitive degenerative diseases. Mycrodose Therapeutics is one of the few private companies that have been granted a Schedule I license and approved by the United States Drug Enforcement Agency (DEA), State of Attorney Generals Research Advisory Board, and the US Food & Drug Administration (FDA) to research four psychedelic compounds: psilocybin, LSD, MDMA, and DMT. The company is based in San Diego, CA, and was founded in 2020. The company's IP-protected sustained microdosing technology™ is a safer and smarter approach to delivering pharmaceutical compounds to patients of all ages, allowing for an expandable and scalable business model. Chad S. Conner has been the CEO of the company since 2020.	Health Technology